New 5H-[1,3]thiazolo[3,2-a]pyrido[3,2-e]pyrimidine derivatives as diuretics.

Arzneimittelforschung

Centro de Investigación en Farmacobiología Aplicada (C.I.F.A.), Universidad de Navarra, Pamplona, Spain.

Published: December 1990

New 5H-[1,3]thiazolo[3,2-a]pyrido[3,2-e]pyrimidines 1 and 6,10-dihydro-5H-pyrido[3',2':5,6]pyrimido[2,1-c] [1,2,4]triazines 4 with 5-one, 5-thione or 5-hydrazono substituents and in some cases 1,2,3,4 or 8,9 hydrogenated are synthetized. The diuretic, natriuretic and kaliuretic activities of these compounds in Wistar rats at a dose of 24 mg/kg were estimated. A series of 24 possible derivatives of 1 and 4 possessing diuretic and saliuretic activities are investigated for structure-activity relationships in light of Fujita-Ban model. The Fujita-Ban group contributions have been calculated for different structural variations on the parent ring 1a. It is observed that the hydrogenation of pyridine, [1,3]thiazole or [1,2,4]triazine rings on 1 or 4 decrease the diuretic and saliuretic activities.

Download full-text PDF

Source

Publication Analysis

Top Keywords

diuretic saliuretic
8
saliuretic activities
8
5h-[13]thiazolo[32-a]pyrido[32-e]pyrimidine derivatives
4
derivatives diuretics
4
diuretics 5h-[13]thiazolo[32-a]pyrido[32-e]pyrimidines
4
5h-[13]thiazolo[32-a]pyrido[32-e]pyrimidines 610-dihydro-5h-pyrido[3'2'56]pyrimido[21-c]
4
610-dihydro-5h-pyrido[3'2'56]pyrimido[21-c] [124]triazines
4
[124]triazines 5-one
4
5-one 5-thione
4
5-thione 5-hydrazono
4

Similar Publications

Changes in blood volume can be caused by different conditions, such as vomiting, diarrhea, alteration of sodium intake, trauma, or the use of diuretics, which can lead to severe health deterioration. Understanding the mechanisms involved in the maintenance of physiological parameters and the hydroelectrolytic balance of the human body during hypovolemia, can help with preventing and handling these high-risk situations. Hence, this study investigated cardiorespiratory [mean arterial pressure (MAP), heart rate (HR), pulmonary ventilation (VE)] and blood parameters, of sodium depleted rats with furosemide and the roles of the central and peripheral renin-angiotensin and the peripheral vasopressinergic systems in controlling blood pressure in these animals.

View Article and Find Full Text PDF

Introduction: (Lamiaceae) has been traditionally used for the treatment of various ailments, including body swelling and urine retention. The present study aimed to evaluate the diuretic activity of a crude extract and solvent fractions of the root bark of . .

View Article and Find Full Text PDF

Background: Although investigations on different pharmacological activities of the experimental plant, have been conducted, its folklore use for diuresis has not yet been validated. The current study, therefore, focused on the diuretic activity of aqueous and 80% methanol extracts of Forssk. leaves in rats.

View Article and Find Full Text PDF

The use of traditional medicines as a diuretic agent has been increasing in recent years. The diuretic activity of a number of plant extracts used as diuretic agents in ethnomedicine has been confirmed in experimental animals. However, despite the widespread use of in traditional medicine, there is a paucity of data supporting its use as a diuretic agent.

View Article and Find Full Text PDF

Effect of lemongrass tea consumption on estimated glomerular filtration rate and creatinine clearance rate.

J Ren Nutr

January 2015

Department of Physiology, College of Health Sciences, University of Calabar, Calabar, Cross River State, Nigeria.

Objectives: The existing research findings regarding the effects of lemongrass (Cymbopogon citratus) tea on renal function indices are conflicting and inconclusive. In the present study, we investigated the effects of infusions prepared from C citratus leaves on creatinine clearance rate (CCr) and estimated glomerular filtration rate (eGFR) in humans.

Design And Methods: One hundred five subjects (55 men and 50 women) aged 18 to 35 years were randomly assigned to groups set to orally receive infusions prepared from 2, 4, or 8 g of C citratus leaf powder once daily, for 30 days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!